Interestingly, an APP missense mutation (A673T) has been described that decreases APP cleavage by β-secretase and lowers the risk of AD and cognitive decline [6] further supporting the critical role of APP-cleavage in AD pathophysiology. The gene discussed is APP; the disease is Alzheimer disease.